机构

• 上海药物研究所 [13]

采集方式

• OAI收割 [13]

内容类型

• 期刊论文 [13]

发表日期

• 2023 [2]
• 2022 [1]
• 2021 [1]
• 2020 [5]
• 2018 [1]
• 2014 [1]
• 更多

学科主题

筛选

浏览/检索结果: 共13条，第1-10条 帮助 限定条件 专题：上海药物研究所    第一署名单位    第一作者单位    通讯作者单位     条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序题名升序题名降序作者升序作者降序发表日期升序发表日期降序 Glimepiride, a novel soluble epoxide hydrolase inhibitor, protects against heart failure via increasing epoxyeicosatrienoic acids 期刊论文  OAI收割 JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2023, 卷号: 185, 页码: 13-25 作者:  Zhao, Chengcheng;  Jiang, Xiangrui;  Peng, Liyuan;  Zhang, Yan;  Li, Huihui   |  收藏  |  浏览/下载：30/0  |  提交时间：2024/01/16 Heart failure  Hypertrophy  Epoxyeicosatrienoic acids  Soluble epoxide hydrolase   Increased Soluble Epoxide Hydrolase Activity Positively Correlates with Mortality in Heart Failure Patients with Preserved Ejection Fraction: Evidence from Metabolomics 期刊论文  OAI收割 Phenomics, 2023, 卷号: 3, 期号: 1, 页码: 34-49 作者:  Peng, Liyuan;  Song, Ziping;  Zhao, Chengcheng;  Abuduwufuer, Kudusi;  Wang, Yanwen   |  收藏  |  浏览/下载：14/0  |  提交时间：2024/03/26 Answer for questions of repeated measurements of variance analysis and distribution test of data - Authors' reply 期刊论文  OAI收割 FRONTIERS OF MEDICINE, 2022, 页码: 5 作者:  Wang, Dao Wen;  Ni, Li;  Jiang, Hualiang   |  收藏  |  浏览/下载：12/0  |  提交时间：2022/08/16 Effects of Shuanghuanglian oral liquids on patients with COVID-19: a randomized, open-label, parallel-controlled, multicenter clinical trial 期刊论文  OAI收割 FRONTIERS OF MEDICINE, 2021, 页码: 14 作者:  Ni, Li;  Wen, Zheng;  Hu, Xiaowen;  Tang, Wei;  Wang, Haisheng   |  收藏  |  浏览/下载：50/0  |  提交时间：2021/08/17 COVID-19  SARS-CoV-2  Shuanghuanglian oral liquid  clinical trial   Beneficial effects exerted by hydroxychloroquine in treating COVID-19 patients via protecting multiple organs 期刊论文  OAI收割 SCIENCE CHINA-LIFE SCIENCES, 2020, 页码: 4 作者:  Yu, Bo   |  收藏  |  浏览/下载：11/0  |  提交时间：2020/12/24 Anti-SARS-CoV-2 activities in vitro of Shuanghuanglian preparations and bioactive ingredients 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 页码: 11 作者:  Su, Hai-xia;  Yao, Sheng;  Zhao, Wen-feng;  Li, Min-jun;  Liu, Jia   |  收藏  |  浏览/下载：62/0  |  提交时间：2020/12/24 SARS-CoV-2  3CL protease  traditional Chinese medicines  Shuanghuanglian oral liquid  baicalin  baicalein   Low dose of hydroxychloroquine reduces fatality of critically ill patients with COVID-19 期刊论文  OAI收割 SCIENCE CHINA-LIFE SCIENCES, 2020, 页码: 7 作者:  Yu Bo;  Li Chenze;  Chen Peng;  Zhou Ning;  Wang Luyun   |  收藏  |  浏览/下载：23/0  |  提交时间：2020/07/01 Discovery of novel CBP bromodomain inhibitors through TR-FRET-based high-throughput screening 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2020, 卷号: 41, 期号: 2, 页码: 286-292 作者:  Zhang, Feng-cai;  Sun, Zhong-ya;  Liao, Li-ping;  Zuo, Yu;  Zhang, Dan   |  收藏  |  浏览/下载：49/0  |  提交时间：2020/07/01 CBP bromodomain  small-molecule inhibitor  high-throughput screening  TR-FRET  molecular modeling  human leukemia MV4-11 cells   Stewartiacids A-N, C-23 carboxylated triterpenoids from Chinese Stewartia and their inhibitory effects against ATP-citrate lyase and NF-kappa B 期刊论文  OAI收割 RSC ADVANCES, 2020, 卷号: 10, 期号: 6, 页码: 3343-3356 作者:  Wan, Jiang;  Zang, Yi;  Xiao, Dao-An;  Li, Na;  Li, Junmin   |  收藏  |  浏览/下载：19/0  |  提交时间：2020/07/01 Development of a high-throughput fluorescence polarization assay for the discovery of EZH2-EED interaction inhibitors 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2018, 卷号: 39, 期号: 2, 页码: 302-310 作者:  Zhu, Mao-rong;  Du, Dao-hai;  Hu, Jun-chi;  Li, Lian-chun;  Liu, Jing-qiu   |  收藏  |  浏览/下载：29/0  |  提交时间：2019/01/08 PRC2  EZH2  EED  protein-protein interaction  fluorescence polarization  high-throughput screening  apomorphine hydrochloride  oxyphenbutazone  nifedipine  ergonovine maleate